Harrison-Dening, Karen
August 2012
British Journal of Neuroscience Nursing;Aug2012, Vol. 8 Issue 4, p204
Academic Journal
The article summarizes new research of interest to neuroscience nurses: a review paper evaluates evidence suggesting that some antihypertensive drugs reduce the risk and progression of Alzheimer's disease more than others; a study uses the Mini Mental State Examination to determine the relationship between hearing impairment and cognitive function; and a systematic review finds that cognitive stimulation interventions benefit cognitive function and wellbeing in people with dementia.


Related Articles

  • Correlations between aggression, depression, and cognitive impairment in elderly care home residents.  // British Journal of Neuroscience Nursing;Aug2012, Vol. 8 Issue 4, p205 

    The article discusses a study that examined the relationship between behavioural and psychological symptoms of dementia (BPSD) and progressive cognitive decline by evaluating cognitive impairment, depressive symptoms, and aggressive behaviour among elderly care home residents. Results showed...

  • Compensatory mechanisms in higher-educated subjects with Alzheimer’s disease: a study of 20 years of cognitive decline. Amieva, Hélène; Mokri, Hind; Le Goff, Mélanie; Meillon, Céline; Jacqmin-Gadda, Hélène; Foubert-Samier, Alexandra; Orgogozo, Jean-Marc; Stern, Yaakov; Dartigues, Jean-François // Brain: A Journal of Neurology;Apr2014, Vol. 137 Issue 4, p1167 

    Education mitigates the long-term trajectory of cognitive decline in Alzheimer’s disease. Amieva et al. report that subtle impairments are detectable up to 16 years before meeting criteria for dementia in highly educated individuals, initially sparing global cognitive abilities. Higher...

  • The Effect of Visual and Audiovisual Competition on the Auditory N1-P2 Evoked Potential. Weihing, Jeffrey; Daniels, Shannon; Musiek, Frank E. // Journal of the American Academy of Audiology;Oct2009, Vol. 20 Issue 9, p569 

    Background: Use of a competition stimuli (e.g., video) in clinical settings is a widespread practice, yet the effects of these stimuli on evoked potentials are not well understood. Purpose: The present investigation acquired the click evoked auditory N1-P2 in quiet and in two types of...

  • PET SCANS FOR AD DIAGNOSIS...DOES ANGER INDICATE WORSE DEPRESSION?..HYPERTENSION AND AD. Fava, Maurizio // Mind, Mood & Memory;Dec2013, Vol. 9 Issue 12, p8 

    The article presents questions and answers related to mind, mood and memory including the link between high blood pressure and increased risk for Alzheimer's disease (AD), irritability and anger as an indication of more severe and longer-lasting depression, and a technique for diagnosing AD.

  • Deterioro cognitivo leve: riesgo de demencia segun subtipos. Serrano, Cecilia M.; Dillon, Carol; Leis, Adriana; Taragano, Fernando E.; Francisco Allegri, Ricardo // Actas Espanolas de Psiquiatria;nov/dic2013, Vol. 41 Issue 6, p330 

    Mild cognitive impairment (MCI) has 3 clinical subtypes: amnestic (aMCI), multiple domains (mdMCI) and nonamnestic single domain (na-SD-MCI) whose evolutive possibility to dementia has not been profoundly studied. Objective: This paper aims to determine the conversion to dementia of the...

  • Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines. Letra, Liliana; Santana, Isabel; Seiça, Raquel // Metabolic Brain Disease;Sep2014, Vol. 29 Issue 3, p563 

    Alzheimer's disease is the leading cause of dementia and the most prevalent neurodegenerative disease. It is an aging-related multi-factorial disorder and growing evidence support the contribution of metabolic factors to what was formerly thought to be a centrally mediated process. Obesity has...

  • Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung, Ging-Yuek R.; Sadovnick, A. Dessa; Feldman, Howard // CMAJ: Canadian Medical Association Journal;10/12/2004, Vol. 171 Issue 8, p863 

    Background: Apolipoprotein E (ApoE) ε4 genotype is a well-established risk factor for Alzheimer's disease (AD). However, its effect on predicting conversion from normal to "cognitive impairment, no dementia" (CIND) and from CIND to AD is less clear. Methods: We used a nested case-control...

  • Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors. Sato, Naoyuki; Morishita, Ryuichi // Frontiers in Aging Neuroscience;Nov2013, Vol. 5, p1 

    It is well known that a specific set of genetic and non-genetic risk factors contributes to the onset of Alzheimer disease (AD). Non-genetic risk factors include diabetes, hypertension in mid-life, and probably dyslipidemia in mid-life. This review focuses on the vascular and metabolic...

  • Aged care: Caregivers focus on dementia.  // Kai Tiaki Nursing New Zealand;Dec2013/Jan2014, Vol. 19 Issue 11, p39 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics